IL2 and hepatocellular carcinoma: GSVA further emphasized that metabolism-related signalling is the main enriched pathway in TKI-resistant HCC, while EMT signalling, the inflammatory response and IL2/STAT5 signalling are the critical characteristic pathways in TKI-sensitive HCC (Figure S1F).